BackCalithera Biosciences Overview

Calithera Biosciences Receivables

Calithera Biosciences's receivables is $0.

Get informed when a big investor buys or sells

+ Follow
Receivables
$0.00

Peer trimmed avg / median

Loading

Calithera Biosciences Receivables History

Loading

Calithera Biosciences vs. peers: Receivables Comparison

Loading

Calithera Biosciences Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Calithera Biosciences (CALA) FAQ

Calithera Biosciences (CALA) currently reports a receivables of $0 as of December 2022. In the prior-year period, the figure was $0. Use the charts on this page to explore Calithera Biosciences's receivables history and peer comparisons.

Calithera Biosciences's receivables changed from $0 to $0 (period ending December 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Calithera Biosciences reported $0 in receivables as of December 2022. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Calithera Biosciences, and consider following CALA for alerts when major investors trade the stock.

Calithera Biosciences is classified in the Healthcare sector. On receivables, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CALA with unrelated industries.